一、题目和背景信息
登记号 |
CTR20250464 |
相关登记号 |
暂无
|
药物名称 |
SHR-2004注射液 |
药物类型 |
生物制品
|
临床申请受理号
|
企业选择不公示 |
适应症 |
预防动静脉血栓 |
试验专业题目 |
评价择期全膝关节置换术患者使用SHR-2004注射液预防静脉血栓栓塞症的有效性和安全性的多中心、随机、双盲、阳性对照III期临床研究 |
试验通俗题目 |
全膝关节置换术患者使用SHR-2004注射液预防静脉血栓栓塞症的III期临床研究 |
试验方案编号 |
SHR-2004-301 |
方案最新版本号
|
2.0 |
版本日期: |
2025-01-10 |
方案是否为联合用药 |
否 |
二、申请人信息
申请人名称 |
[["北京盛迪医药有限公司"],["苏州盛迪亚生物医药有限公司"]] |
联系人姓名 |
聂状 |
联系人座机 |
0518-82342973 |
联系人手机号 |
|
联系人Email |
zhuang.nie@hengrui.com |
联系人邮政地址 |
江苏省-连云港市-经济技术开发区昆仑山路7号 |
联系人邮编 |
222047 |
三、临床试验信息
1、试验目的
主要目的:评价行择期全膝关节置换术的患者使用SHR-2004注射液在治疗期间预防术后总静脉血栓栓塞症的有效性。
次要目的:评价行择期TKA患者使用SHR-2004注射液的安全性、药代动力学特征、药效动力学特征、免疫原性等。
2、试验设计
试验分类 |
安全性和有效性 |
试验分期 |
III期
|
设计类型 |
平行分组
|
随机化 |
随机化
|
盲法 |
双盲
|
试验范围 |
国内试验
|
3、受试者信息
年龄 |
18岁(最小年龄)至
80岁(最大年龄) |
性别 |
男+女
|
健康受试者 |
无
|
入选标准 |
[["自愿签署知情同意书。"],["拟行择期TKA的患者。"],["签署知情同意书当日年龄≥18周岁且<80周岁的男性或女性。"]]
|
排除标准 |
[["经研究者判断预期无法接受双下肢静脉CT血管成像检查者。"],["筛选前1年内患有恶性肿瘤(经根治性治疗的非黑色素瘤皮肤癌或宫颈原位癌除外)。"],["可能增加出血风险的病史或研究者认为有增加出血风险的任何情况。"],["筛选时患有不稳定的或严重的肝脏、肾脏、心血管、精神、神经、内分泌、血液学等疾病,研究者判定参与研究会使受试者处于不可接受的风险中。"],["任何其他有临床意义的异常实验室值、且经研究者判定不适合入组。"],["有吸毒史或药物滥用史者。"],["妊娠或哺乳期的女性。"]]
|
4、试验分组
试验药 |
序号 |
名称 |
用法 |
[["中文通用名:SHR-2004注射液 英文通用名:SHR-2004injection 商品名称:NA","剂型:注射液 规格:1.0ml:0.12g/瓶 用法用量:皮下注射,用药日用药一次,120mg;或静脉滴注,用药日用药一次,90mg。 用药时程:共用药1次。"]]
|
对照药 |
序号 |
名称 |
用法 |
[["中文通用名:SHR-2004安慰剂 英文通用名:SHR-2004placebo 商品名称:NA","剂型:注射液 规格:1.0ml/瓶 用法用量:皮下注射,用药日用药一次,1.0ml;或静脉滴注,用药日用药一次,0.75ml。 用药时程:共用药1次。"],["中文通用名:依诺肝素钠注射液 英文通用名:Enoxaparinsodiuminjection 商品名称:百力佳","剂型:注射液 规格:0.4ml:4000AxaIU/支 用法用量:皮下注射,每日一次,每次40mg。 用药时程:共用药12-14次。"],["中文通用名:依诺肝素钠安慰剂 英文通用名:Enoxaparinsodiuminjectionplacebo 商品名称:NA","剂型:注射液 规格:0.4ml/支 用法用量:皮下注射,每日一次,每次40mg。 用药时程:共用药12-14次。"]]
|
5、终点指标
主要终点指标及评价时间 |
序号 |
指标 |
评价时间 |
终点指标选择 |
[["VTE和全因死亡的发生率。","首次用药至治疗期结束。","有效性指标"],["符合大出血和临床相关非大出血事件的复合终点发生率。","首次用药至治疗期结束。","安全性指标"]]
|
次要终点指标及评价时间 |
序号 |
指标 |
评价时间 |
终点指标选择 |
[["主要疗效终点的各组分事件发生率。","首次用药至治疗期结束。","有效性指标"],["重大VTE和全因死亡的发生率。","首次用药至随访结束。","有效性指标"],["总VTE和全因死亡的发生率及各组分事件发生率。","首次用药至治疗期结束。","有效性指标"],["重大VTE和全因死亡的发生率。","首次用药至随访结束。","有效性指标"],["主要安全性终点各组分事件发生率。","首次用药至治疗期结束。","安全性指标"],["任何出血事件的发生率。","首次用药至随访结束。","安全性指标"],["符合大出血和临床相关非大出血事件的复合终点发生率。","首次用药至随访结束。","安全性指标"],["不良事件的发生率及严重程度。","首次用药至随访结束。","安全性指标"]]
|
四、研究者信息
1、主要研究者信息
1 |
姓名 |
雷光华 |
学位 |
医学博士 |
职称 |
教授 |
电话 |
0731-89753999 |
Email |
lei_guanghua@csu.edu.cn |
邮政地址 |
湖南省-长沙市-开福区湘雅路87号 |
邮编 |
410008 |
单位名称 |
中南大学湘雅医院 |
2、各参加机构信息
序号 |
机构名称 |
主要研究者 |
国家 |
省(州) |
城市 |
[["中南大学湘雅医院","雷光华","中国","湖南省","长沙市"],["中国人民解放军总医院第四医学中心","唐佩福","中国","北京市","北京市"],["安徽医科大学第二附属医院","姚运峰","中国","安徽省","合肥市"],["北京大学深圳医院","王德利","中国","广东省","深圳市"],["北京积水潭医院贵州医院","张骏","中国","贵州省","贵阳市"],["北京清华长庚医院","蔡谞","中国","北京市","北京市"],["北京医院","薛庆云","中国","北京市","北京市"],["成都市第五人民医院","刑叔星","中国","四川省","成都市"],["常德市第一人民医院","林谦","中国","湖南省","常德市"],["赤峰市医院","孙智文","中国","内蒙古自治区","赤峰市"],["重庆医科大学附属第二医院","聂茂","中国","重庆市","重庆市"],["常州市第二人民医院","徐南伟","中国","江苏省","常州市"],["常州市第一人民医院","王益民","中国","江苏省","常州市"],["郴州市第一人民医院","肖勋刚","中国","湖南省","郴州市"],["池州市人民医院","谢贵杰","中国","安徽省","池州市"],["大连大学附属中山医院","王铁男","中国","辽宁省","大连市"],["复旦大学附属中山医院","阎作勤","中国","上海市","上海市"],["福建医科大学附属第一医院","张文明","中国","福建省","福州市"],["福建医科大学附属协和医院","陈敏","中国","福建省","福州市"],["广东省人民医院","郑秋坚","中国","广东省","广州市"],["甘肃省人民医院","郭洪章","中国","甘肃省","兰州市"],["赣州市人民医院","肖军","中国","江西省","赣州市"],["广州医科大学附属第一医院","卢伟杰","中国","广东省","广州市"],["贵州医科大学附属医院","李江伟","中国","贵州省","贵阳市"],["广州中医药大学第一附属医院","王海彬","中国","广东省","广州市"],["淮北矿工总医院","陈亮","中国","安徽省","淮北市"],["河北省沧州中西医结合医院","李晓明","中国","河北省","沧州市"],["河北省人民医院","李文毅","中国","河北省","石家庄市"],["河北医科大学第三医院","董江涛","中国","河北省","石家庄市"],["河北医科大学第一医院","刘国彬","中国","河北省","石家庄市"],["合肥市第二人民医院","储建军","中国","安徽省","合肥市"],["合肥市第一人民医院","宁仁德","中国","安徽省","合肥市"],["核工业总医院(苏州大学附属第二医院)","周晓中","中国","江苏省","苏州市"],["河南大学第一附属医院","杨广杰","中国","河南省","开封市"],["吉林大学第一医院","齐欣","中国","吉林省","长春市"],["吉林大学第一医院梅河医院(梅河口市中心医院)","宋洪光","中国","吉林省","通化市"],["江门市中心医院","邬黎平","中国","广东省","江门市"],["暨南大学附属第一医院(广州华侨医院)","侯辉歌","中国","广东省","广州市"],["济南市中心医院","郭舒亚","中国","山东省","济南市"],["济宁医学院附属医院","陈国武","中国","山东省","济宁市"],["江西省人民医院(南昌医学院第一附属医院)","陈钢","中国","江西省","南昌市"],["江阴市人民医院","姜雪峰","中国","江苏省","无锡市"],["昆明医科大学第一附属医院","王兵","中国","云南省","昆明市"],["喀什地区第一人民医院","阿力木·克热木","中国","新疆维吾尔自治区","喀什地区"],["聊城市人民医院","苑振峰","中国","山东省","聊城市"],["丽水市中心医院","何登伟","中国","浙江省","丽水市"],["连云港市第一人民医院","秦入结","中国","江苏省","连云港市"],["柳州市人民医院","彭伟秋","中国","广西壮族自治区","柳州市"],["宁波大学附属第一医院","朱迎春","中国","浙江省","宁波市"],["南昌大学第二附属医院","程细高","中国","江西省","南昌市"],["南方医科大学第三附属医院、广东省骨科医院","曾春","中国","广东省","广州市"],["内蒙古自治区人民医院","徐永胜","中国","内蒙古自治区","呼和浩特市"],["南通大学附属医院","刘璠","中国","江苏省","南通市"],["南阳市第二人民医院","尚立林","中国","河南省","安阳市"],["濮阳市人民医院","马方南","中国","河南省","濮阳市"],["濮阳油田总医院(濮阳市油田总医院)","刘涛","中国","河南省","濮阳市"],["攀枝花市中心医院","钟凤林","中国","四川省","攀枝花市"],["齐齐哈尔市第一医院","林林","中国","黑龙江省","齐齐哈尔市"],["苏北人民医院","颜连启","中国","江苏省","扬州市"],["四川大学华西医院","康鹏德","中国","四川省","成都市"],["山东大学第二医院","刘胜厚","中国","山东省","济南市"],["山东大学齐鲁医院","刘培来","中国","山东省","济南市"],["山东第一医科大学第一附属医院(山东省千佛山医院)","吴剑波","中国","山东省","济南市"],["首都医科大学附属北京积水潭医院","徐辉","中国","北京市","北京市"],["首都医科大学附属北京潞河医院","刘亮","中国","北京市","北京市"],["首都医科大学宣武医院","鲁世保","中国","北京市","北京市"],["上海市东方医院","尹峰","中国","上海市","上海市"],["上海市浦东医院","姜新华","中国","上海市","上海市"],["三门峡市中心医院","丁韶龙","中国","河南省","三门峡市"],["上饶市人民医院","吴国保","中国","江西省","上饶市"],["汕头大学医学院第一附属医院","胡军","中国","广东省","汕头市"],["绍兴第二医院医共体总院(绍兴第二医院)","马一鸣","中国","浙江省","绍兴市"],["陕西省人民医院","刘时璋","中国","陕西省","西安市"],["绍兴市人民医院","李宏斌","中国","浙江省","绍兴市"],["山西医科大学第二医院","冯毅","中国","山西省","太原市"],["沈阳市骨科医院","柳椰","中国","辽宁省","沈阳市"],["沈阳医学院附属中心医院","赵伟","中国","辽宁省","沈阳市"],["深圳市人民医院","李广恒","中国","广东省","深圳市"],["天津市天津医院","刘军","中国","天津市","天津市"],["天津医科大学总医院","宁广智","中国","天津市","天津市"],["潍坊市人民医院","王炳武","中国","山东省","潍坊市"],["无锡市中医医院","张亚峰","中国","江苏省","无锡市"],["温州医科大学附属第二医院","陈华","中国","浙江省","温州市"],["温州医科大学附属第一医院","陈雷","中国","浙江省","温州市"],["西安市红会医院","马建兵","中国","陕西省","西安市"],["新疆维吾尔自治区人民医院","王利","中国","新疆维吾尔自治区","乌鲁木齐市"],["徐州医科大学附属医院","周冰","中国","江苏省","徐州市"],["宜昌市中心人民医院(伍家院区)","寿康全","中国","湖北省","宜昌市"],["宜昌市中心人民医院(西陵院区)","梁杰","中国","湖北省","宜昌市"],["运城市中心医院","周志康","中国","山西省","运城市"],["玉林市中西医结合骨科医院","梁雄伟","中国","广西壮族自治区","玉林市"],["云南省滇南中心医院(红河哈尼族彝族自治州第一人民医院)","曾德妙","中国","云南省","红河哈尼族彝族自治州"],["阳泉煤业(集团)有限责任公司总医院","王汝江","中国","山西省","阳泉市"],["烟台毓璜顶医院","王光达","中国","山东省","烟台市"],["中国人民解放军联勤保障部队第九六〇医院","于秀淳","中国","山东省","济南市"],["中国医科大学附属第一医院","朱悦","中国","辽宁省","沈阳市"],["中国医科大学附属盛京医院","商冠宁","中国","辽宁省","沈阳市"],["浙江省人民医院毕节医院","张骏","中国","贵州省","毕节市"],["中南大学湘雅二医院","黄添隆","中国","湖南省","长沙市"],["中南大学湘雅三医院","吴松","中国","湖南省","长沙市"],["遵义医科大学附属医院","彭笳宸","中国","贵州省","遵义市"],["东南大学附属中大医院","陆军","中国","江苏省","南京市"],["铜陵市人民医院","夏良政","中国","安徽省","铜陵市"]]
五、伦理委员会信息
序号 |
名称 |
审查结论 |
批准日期/备案日期 |
[["中南大学湘雅医院临床医学伦理委员会","同意","2024-09-24"],["中南大学湘雅医院临床医学伦理委员会","同意","2025-01-21"]]
六、试验状态信息
1、试验状态
进行中(尚未招募)
2、试验人数
目标入组人数 |
国内: 1167 ; |
已入组人数 |
国内: 登记人暂未填写该信息; |
实际入组总人数 |
国内: 登记人暂未填写该信息; |
3、受试者招募及试验完成日期
第一例受试者签署知情同意书日期 |
国内:登记人暂未填写该信息; |
第一例受试者入组日期 |
国内:登记人暂未填写该信息; |
试验完成日期
|
国内:登记人暂未填写该信息; |